0.15 EUR
1.02 M EUR
5.04 M EUR
About Vytrus Biotech SA
Sector
Industry
Website
Headquarters
Barcelona
Founded
2009
ISIN
ES0105618005
FIGI
BBG0160ZL316
Vytrus Biotech SA is a biotechnology company, which engages in the development of cosmetic active ingredients from plant stem cell technology. The company was founded by Òscar Expósito Tarrés and Albert Jané Font in June 2009 and is headquartered in Barcelona, Spain.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VYT is 5.85 EUR — it hasn't changed in the past 24 hours. Watch Vytrus Biotech SA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BME exchange Vytrus Biotech SA stocks are traded under the ticker VYT.
VYT stock has risen by 6.36% compared to the previous week, the month change is a 6.36% rise, over the last year Vytrus Biotech SA has showed a 147.88% increase.
VYT stock is 0.00% volatile and has beta coefficient of −0.06. Track Vytrus Biotech SA stock price on the chart and check out the list of the most volatile stocks — is Vytrus Biotech SA there?
Yes, you can track Vytrus Biotech SA financials in yearly and quarterly reports right on TradingView.
VYT net income for the last half-year is 510.28 K EUR, while the previous report showed 510.72 K EUR of net income which accounts for −0.09% change. Track more Vytrus Biotech SA financial stats to get the full picture.
No, VYT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 16, 2025, the company has 37 employees. See our rating of the largest employees — is Vytrus Biotech SA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Vytrus Biotech SA EBITDA is 1.81 M EUR, and current EBITDA margin is 34.45%. See more stats in Vytrus Biotech SA financial statements.
Like other stocks, VYT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vytrus Biotech SA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Vytrus Biotech SA technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Vytrus Biotech SA stock shows the buy signal. See more of Vytrus Biotech SA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.